1Assaad D, From L, Ricciatti D, et al. Toxic epidermal necrolysis in Stevens-Johnson syndrome. Can Med Assoc J 1978; 118:154 -156.
2Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600- 1607.
3Bastuji-Garin S, Rzany B, Stern RS, et al.Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome,and erythema multiforme. Arch Dermatol1999;129:92-96.
4王贤才.临床药物大典(Drug Evaluation).青岛:青岛出版社,1994.12.
5孙琛.临床药物大全.第1版.上海:中国大百科全书出版社上海分社,1995.5.
6Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 2002;8:5.
7Wolkenstein P, Revuz J. Drug-induced severe skin reactions. Incidence management and prevention. Drug Saf 1995;13:56-68.
8Schulz JT, Sheridan RL, Ryan Cm, et al. A 10-year experience with toxic epidermal necrolysis. Burn Care Rehabil 2000; 21:199-204.
9Guillaume JC, Roujeau JC, Revuz J, et al.The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch dermatol 1987;123:1166- 1170.
